|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2000033538 |
|
最近更新日期: Date of Last Refreshed on: |
2020-06-13 01:05:20 |
|
注册时间: Date of Registration: |
2020-06-12 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
儿童结肠镜肠道准备方案优化研究,小佰太能联合小剂量 PEG 对比高剂量 PEG 肠 道准备方案在儿童肠道准备中的非劣效研究 |
|
Public title: |
Study on optimization of bowel preparation plan for colonoscopy in children,Study on non-inferiority effect of Small dosage PEG combined with high dosage PEG in intestinal preparation of children |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
儿童结直肠息肉管理项目 |
|
Scientific title: |
Pediatric colorectal polyp care |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王华 |
研究负责人: |
方莹 |
|
Applicant: |
Hua Wang |
Study leader: |
Ying Fang |
|
申请注册联系人电话: Applicant telephone: |
+86 15929966590 |
研究负责人电话:
Study leader's |
+86 18602907819 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
15929966590@163.com |
研究负责人电子邮件: Study leader's E-mail: |
970910576@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
陕西省西安市西举院巷69号 |
研究负责人通讯地址: |
陕西省西安市西举院巷69号 |
|
Applicant address: |
NO.69 Juyuan Lane West, Xi'an, Shaanxi, China |
Study leader's address: |
NO.69 Juyuan Lane West, Xi'an, Shaanxi, China |
|
申请注册联系人邮政编码: Applicant postcode: |
710003 |
研究负责人邮政编码: Study leader's postcode: |
710003 |
|
申请人所在单位: |
西安市儿童医院 |
||
|
Applicant's institution: |
Xi'an Children's Hospital |
||
|
研究负责人所在单位: |
西安市儿童医院 |
||
|
Affiliation of the Leader: |
Xi'an Children's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2020-001-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
西安市儿童医院药物临床试验伦理委员会 |
||
|
Name of the ethic committee: |
Medical Clinical Trial Ethics Committee of Xi'an Children's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-05-28 00:00:00 | ||
|
伦理委员会联系人: |
苟凯华 |
||
|
Contact Name of the ethic committee: |
Kaihua Gou |
||
|
伦理委员会联系地址: |
陕西省西安市西举院巷69号 |
||
|
Contact Address of the ethic committee: |
NO.69 Juyuan Lane West, Xi'an, Shaanxi, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
西安市儿童医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Xi'an Children's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
陕西省西安市西举院巷69号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
NO.69 Juyuan Lane West, Xi'an, Shaanxi, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
基金会及自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Foundations and self-financing |
||||||||||||||||||||||
|
研究疾病: |
儿童结直肠息肉 |
||||||||||||||||||||||
|
Target disease: |
Pediatric colorectal polyps |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
完善优化儿童结肠镜检查围手术期肠道准备流程、方案 |
||||||||||||||||||||||
|
Objectives of Study: |
Improve and optimize the procedures and protocols of bowel preparation during perioperative period of colonoscopy in children |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)年龄1~18周岁接受结肠镜检查的患儿; |
||||||||||||||||||||||
|
Inclusion criteria |
1. Children aged 1-18 years who received colonoscopy; |
||||||||||||||||||||||
|
排除标准: |
(1)患有心肺疾病或其他严重基础疾病; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with cardiopulmonary disease or other serious basic diseases; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2019-08-01 00:00:00至 To 2022-08-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-08-10 00:00:00 至 To 2022-04-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
如果患者符合本研究的入组条件,在签署书面知情同意书并且研究医师认为该患者具备研究资格后,将采用随机数表法对患者进行随机分配,具体为:从随机数表法中任意一个随机数字开始,向右连续选取数字,纳入研究的患儿按照就诊顺序依次对应连续的随机数字,随机数字按照大小分组后入各组别。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
If the patients are eligible for inclusion in the studys, with a written informed consent and the study doctor thinks the patient conform to the qualified research, Patients were randomly assigned using the random number table methods. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
未说明 |
|
Blinding: |
Not stated |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2023年2月份, 网络平台 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
February 2023, network platform |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集和管理基于互联网,质控组定期审查 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection and management based on the Internet, quality control group regularly review |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |